23 July 2014 – final results
The group has announced its results for the year to 30 April, although as usual these are not particularly relevant. The sale of Geomerics during the year for up to £6.2m has allowed the group to focus on its main Parsortix business whilst also helping to provide additional funds to help fund its development. Considerable progress has been made with this which has c0ontinued after the year end and interest in the product continues to grow. As with all such businesses which are seeking to develop new technology and bring it to a level where it can be commercialised the shares are not without risk but we remain optimistic that patient shareholders will be rewarded in due course. LONG TERM BUY.